BioCentury
ARTICLE | Company News

Ablynx, Algeta in cancer Nanobodies deal

November 21, 2012 11:36 PM UTC

Ablynx N.V. (Euronext:ABLX) and Algeta ASA (OSE:ALGETA) partnered to evaluate a targeted thorium conjugate (TTC) of Algeta's thorium-227, an alpha-particle emitting radionuclide, and Ablynx's Nanobodi...